A Phase IIa Withdrawal Study of CNV1014802 in Patients With Trigeminal Neuralgia

NCT01540630 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

67

Enrollment

INDUSTRY

Sponsor class

Conditions

Trigeminal Neuralgia

Interventions

DRUG: CNV1014802
DRUG: Placebo

Sponsor

Biogen